Merck & Co Inc logo

Merck & Co Inc

LTS:0QAH (USA)  
$ 102.30 (-1.25%) Oct 2
On watch
P/E:
82.66
P/B:
6.62
Market Cap:
$ 260.22B
Enterprise V:
$ 290.76B
Volume:
1.24M
Avg Vol (2M):
176.72K
Also Trade In:
Volume:
1.24M
Market Cap $:
260.22B
PE Ratio:
82.66
Avg Vol (2M):
176.72K
Enterprise Value $:
290.76B
PB Ratio:
6.62

Business Description

Description
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

Financials (Next Earnings Date:2023-10-27 Est.)

LTS:0QAH's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Merck & Co Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 58,311
EPS (TTM) ($) 1.22
Beta 0.31
Volatility % 23.12
14-Day RSI 26.33
14-Day ATR ($) 1.623759
20-Day SMA ($) 106.585
12-1 Month Momentum % 25.51
52-Week Range ($) 86.2273 - 119.56
Shares Outstanding (Mil) 2,537.52

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Merck & Co Inc Filings

Filing Date Document Date Form
No Filing Data

Merck & Co Inc Stock Events

Event Date Price($)
No Event Data

Merck & Co Inc Frequently Asked Questions

What is Merck & Co Inc(LTS:0QAH)'s stock price today?
The current price of LTS:0QAH is $102.30. The 52 week high of LTS:0QAH is $119.56 and 52 week low is $86.23.
When is next earnings date of Merck & Co Inc(LTS:0QAH)?
The next earnings date of Merck & Co Inc(LTS:0QAH) is 2023-10-27 Est..
Does Merck & Co Inc(LTS:0QAH) pay dividends? If so, how much?
The  Dividend Yield %  of Merck & Co Inc(LTS:0QAH) is 2.85% (As of Today), Highest Dividend Payout Ratio of Merck & Co Inc(LTS:0QAH) was 2.36. The lowest was 0.44. And the median was 1.09. The  Forward Dividend Yield % of Merck & Co Inc(LTS:0QAH) is 2.85%. For more information regarding to dividend, please check our Dividend Page.

Press Release

Subject Date
No Press Release